Globe Newswire
Marimekko Corporation, Press release, 6 May 2024 at 9.30 a.m.
Marimekko celebrates the 60th anniversary of the Unikko print in Helsinki and Tokyo with public open-air fashion shows
The annual Marimekko Day is celebrated in mid-May with a public open-air fashion show in Helsinki and in Marimekko stores globally. To celebrate the 60-year-old iconic Unikko print, the fashion show will also be seen in Tokyo for the first time.
Esplanade Park in the... (continue reading...)
2024 FINANCIAL CALENDAR - Update
Paris, 6 May 2024
Q1 2024 sales: 27 May 2024*
- Quiet period: from 13 May to 27 May 2024
Annual General Meeting: 14 June 2024
New date – Capital Markets Day: 19 June 2024
Update – Half-year results and Q2 2024 sales: 23 September 2024*
- Update – Quiet period: from 9 to 23 September 2024
Q3 2024 sales: 27 November 2024*
- Quiet period: from 13 to 27 November 2024
* Publication after the closing of the Premier Marché of... (continue reading...)
Amsterdam, 6 May 2024
EXOR N.V.: PERIODIC REPORT ON THE BUYBACK PROGRAM
Exor N.V. (AMS: EXO) (“Exor” or the “Company”) announces that, under the first tranche of the share buyback program of up to €125 million announced on 15 April 2024 (the “first tranche”), the Company has completed the following transactions on Euronext Amsterdam and CBOE DXE:
EURONEXT AMSTERDAM
Trading DateNumber of ordinary shares purchasedAverage price per share excluding fees... (continue reading...)- Completion of the additional equity investment of $140M by AstraZeneca, as previously announced on November 1 and 15, 2023
NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS – NASDAQ: CLLS) a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced that, following clearance from the French Ministry of Economy and satisfaction of all other closing... (continue reading...)
Press release, Helsinki, 6 May 2024 at 9 AM (EEST)
Health Canada Approves Nexstim NBS 6 System for Treatment of MDD
Nexstim Plc (NXTMH:HEX) ("Nexstim" or "Company") has received approval from Health Canada for the marketing and commercial distribution of its NBS 6 system for the treatment of Major Depressive Disorder (MDD).
Released in the EU and the United States in 2023, the NBS 6 is a new generation Nexstim system. The NBS 6 is currently FDA-approved for the... (continue reading...)
More Globe Newswire
View Older Stories-
Aktsiaselts Infortar interim report for Q1 2024
-
Fingerprints and Infrafon collaborating on new smart badges for the European Medical and IoT market
-
Subsea7 share repurchases
-
BGHL (GBP): NAV(s)
-
BGHL (EUR): NAV(s)
-
Declaration of shares and voting rights April 30, 2024 - VALNEVA SE
-
Transaction in Own Shares
-
TGS Secures New Ocean Bottom Node Data Acquisition Contract in North America
-
Corbion reports the progress of its € 20 million share buyback program 29 April – 3 May 2024
-
Start of Day Message
-
Market Update
-
Subc – Ex. Dividend Nok 3.00 Today
-
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Personalized Medicine in Middle East and North Africa (MEA) Region
-
Dividend Payments Ex-date of AS Tallinna Sadam
-
Invitation to DNO Q1 2024 Earnings Call
-
Revised agenda of the Ordinary General Meeting of 21 May 2024
-
GroveX Sets New Standards in Cryptocurrency Trading with Rapid Growth and Innovative Features
-
Studies Show Diabetes Medicine Can Cause Urologic Complications
-
Flash News: OKX Wallet Now Integrated with LiquiX
-
DOCS INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Doximity, Inc. Investors with Substantial Losses Have Opportunity to Lead Case
-
Flash News: OKX Wallet Now Integrated with BitGenie
-
Research Presented at AUA 2024 Indicates the Cost of Prescription Drugs Is A Significant Barrier To Care
-
Boyu to Showcase Cutting-Edge SPC Flooring Production Lines at NPE2024
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages PowerSchool Holdings, Inc. Investors to Inquire About Securities Class Action Investigation – PWSC
-
Research Demonstrates How Technology and AI Can Improve Urologic Health
-
Churchill Downs Incorporated and NBC Sports Extend Historic Partnership
-
Mystik Dan Wins the Historic 150th Running of the Kentucky Derby Presented by Woodford Reserve
-
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Equinix, Inc. with Losses to Contact the Firm
-
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Cryoport, Inc. and Encourages Investors to Contact the Firm
-
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sprout Social, Inc. and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against SpaceMobile, Rivian, Compass Minerals, and Malibu Boats and Encourages Investors to Contact the Firm
-
IRSA: China and France aspire to provide a positive example for peaceful interactions between traditional and emerging powers
-
IRSA: Chinese President Xi Jinping’ s visit to France opens a new chapter in China-EU relations
-
IRSA: France and China embrace new chances for cultural interchange, as well as economic and commercial collaboration
-
IRSA: Win-win cooperation, China-France cooperation begins a new journey
-
Studies Show Continued Efficacy of New UTI Vaccine
-
ODU Confers More Than 2,600 Degrees During its 2024 Spring Commencement Exercises
-
Studies Presented at AUA 2024 Highlight Latest Research on Voiding Dysfunction and BPH
-
AKRO INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Akero Therapeutics, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Case
-
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Northern Genesis Acquisition Corp. n/k/a The Lion Electric Company Investors to Secure Counsel Before Important Deadline in Securities Class Action – NGA
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ocugen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – OCGN
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – QDEL
-
INVESTOR DEADLINE APPROACHING: Robbins Geller Rudman & Dowd LLP Announces that The Chemours Company Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - CC
-
ROSEN, A TOP RANKED LAW FIRM, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation – ZTS
-
Studies Find Erectile Dysfunction Commercial Bias Is More Prevalent On TikTok Than YouTube
-
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Perion Network Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action – PERI
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages AXT, Inc. Investors to Inquire About Securities Class Action Investigation – AXTI
-
LNC INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Lincoln National Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Exscientia, and Akero and Encourages Investors to Contact the Firm
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against HireRight, Doximity, Global Cord, and Lincoln Innovations and Encourages Investors to Contact the Firm
